The Preclinical Disease Models facility provides researchers with validated model systems to study cancer biology and evaluate therapeutic candidates before clinical translation. The platform encompasses both cell-based and organism-based approaches, enabling investigators to assess drug responses, resistance mechanisms, and combination strategies in controlled experimental settings. All work is conducted under institutional ethical oversight with emphasis on the 3Rs principles.
Patient-derived organoid and spheroid culture systems for personalized drug sensitivity testing
Established cancer cell line panels representing major tumor types treated at the institute
In vivo efficacy and pharmacokinetic studies conducted under institutional ethical approval
3D co-culture and tumor microenvironment modeling platforms
High-content screening for compound library evaluation
Researchers interested in using this facility can request access by contacting the facility management team. Training sessions and orientation are available for new users.
Direct Enquiry: facilities@cancerinstitutewia.org
.png&w=96&q=75){kind=small}